Myotonic dystrophy is a complex inherited condition that progressively weakens muscles and affects multiple body systems, causing prolonged muscle contractions that make it difficult to relax muscles after use. While there is no cure, understanding the condition and managing its symptoms can significantly improve quality of life for those living with this form of muscular dystrophy.

What is Myotonic Dystrophy?

Myotonic dystrophy is a type of muscular dystrophy, which refers to a group of inherited conditions that cause muscles to gradually become weaker and smaller over time. What makes myotonic dystrophy unique is a symptom called myotonia, which means muscles cannot relax properly after they contract. For instance, someone with this condition might have trouble releasing their grip on a doorknob after grasping it, or their jaw might temporarily lock after speaking^[1].

This condition affects more than just skeletal muscles used for movement. It can impact the heart, eyes, digestive system, hormone-producing glands, and the central nervous system. The complexity of myotonic dystrophy means that people with this condition may experience a wide variety of symptoms that affect different parts of their body^[1].

There are two main types of myotonic dystrophy. Type 1, also known as Steinert disease, tends to be more severe and is divided into four subtypes depending on when symptoms begin: classic, mild, congenital (present at birth), and childhood-onset. Type 2, sometimes called proximal myotonic myopathy, is generally milder than type 1. Both types share similar symptoms, but they affect slightly different muscle groups and have different patterns of inheritance^[1].

Epidemiology: How Common is Myotonic Dystrophy?

Myotonic dystrophy affects at least 1 in 8,000 people worldwide, though recent genetic studies suggest the actual number may be significantly higher. One study examining newborn screening data estimated the prevalence to be approximately 1 in 2,100 individuals, which is much more common than previously thought^[11][1].

The condition’s prevalence varies considerably among different geographic regions and ethnic populations. Myotonic dystrophy is the most common form of muscular dystrophy in people of European ancestry. In most populations around the world, type 1 is more common than type 2. However, recent research from Germany and Finland suggests that type 2 may be as common as type 1 in those regions^[3][4].

Among nonwhite populations, myotonic dystrophy type 1 is uncommon or rare. Some regions show particularly high rates of the condition. For example, in Quebec, Canada, the incidence has been reported as high as 1 in 500 people, likely due to a founder effect where a genetic variant becomes common in a geographically isolated population^[3][2].

Different forms of myotonic dystrophy affect people at different ages. Classic type 1 typically begins in a person’s 20s, 30s, or 40s. Mild type 1 usually affects people between ages 20 and 70, most commonly after age 40. Congenital type 1 is present at birth, while childhood-onset type 1 usually begins around age 10. Type 2 typically starts in adulthood, with an average age of onset around 48 years^[1].

Causes: Understanding the Genetic Origins

Myotonic dystrophy is caused by genetic mutations that are passed down through families. Both type 1 and type 2 result from abnormal expansions of DNA sequences, though in different genes. In type 1, the problem occurs in a gene called DMPK located on chromosome 19, where a three-letter DNA sequence (cytosine-thymine-guanine, or CTG) repeats too many times. In type 2, a four-letter sequence (cytosine-cytosine-thymine-guanine, or CCTG) repeats excessively in a gene called ZNF9 (also known as CNBP) on chromosome 3^[3][4].

When these DNA sequences repeat abnormally, they create unusually long messenger RNA molecules. These abnormal RNA molecules form clumps inside cells that trap important proteins, particularly one called muscleblind protein. This disrupts many cellular processes, including how genes are read and how proteins are made. The result is dysfunction in muscle cells and cells in other tissues throughout the body, leading to the wide range of symptoms seen in myotonic dystrophy^[4][11].

The severity of myotonic dystrophy type 1 is related to the number of CTG repeats. People with fewer than 35 repeats are considered normal. Those with more than 50 repeats typically show clinical symptoms, and the more repeats present, the more severe the disease tends to be. Importantly, when the condition is passed from parent to child, the number of repeats often increases, a phenomenon called anticipation. This means the condition can become more severe and appear earlier in subsequent generations^[3].

Risk Factors: Who is at Higher Risk?

The primary risk factor for myotonic dystrophy is having a family history of the condition. Myotonic dystrophy is inherited in an autosomal dominant pattern, which means a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. If one parent has myotonic dystrophy, each child has a 50% chance of inheriting the genetic mutation^[4].

People of European ancestry are at higher risk for developing myotonic dystrophy compared to other ethnic groups, where the condition is uncommon or rare. Certain geographic regions, such as Quebec, have particularly high rates due to founder effects in their populations^[3][2].

Because of the anticipation phenomenon, children of parents with myotonic dystrophy face not only the risk of inheriting the condition but also the possibility of developing a more severe form at an earlier age than their affected parent. This is especially true when the gene is passed from mother to child. Women with myotonic dystrophy who become pregnant face the risk of having a baby with the severe congenital form of the condition^[3].

Age is not a traditional risk factor since myotonic dystrophy is genetic, but the age at which symptoms appear depends on the specific type of myotonic dystrophy a person has inherited. Classic type 1 typically manifests in early to middle adulthood, while type 2 usually appears later, around age 48 on average^[1].

Symptoms: How Myotonic Dystrophy Affects the Body

The hallmark symptoms of myotonic dystrophy are progressive muscle wasting, muscle weakness, and myotonia. These symptoms gradually worsen over time. Myotonia, the inability to relax muscles after voluntary contraction, is often one of the first symptoms people notice. It typically becomes more obvious after rest and improves with repeated muscle activity. Cold temperatures can make myotonia worse^[1][3].

In classic myotonic dystrophy type 1, muscle weakness typically affects the distal muscles first—those farthest from the center of the body. This includes muscles in the hands, forearms, lower legs, and feet. People may have difficulty with fine motor tasks like buttoning shirts or writing. They may develop foot drop, causing an impaired walking pattern. Facial muscles also become weak and waste away, creating a characteristic thin, sharp facial appearance sometimes called a myopathic face^[1].

Type 2 myotonic dystrophy primarily affects proximal muscles, those closer to the center of the body, such as muscles in the neck, shoulders, elbows, and hips. Type 2 tends to be milder overall than type 1^[4].

Beyond muscle symptoms, myotonic dystrophy can cause a wide range of problems in other body systems. Many people develop cataracts, which are clouding of the eye’s lens, often appearing before age 50. These can be a distinctive blue-dot type or posterior subcapsular cataracts. Heart problems are common and can be serious, particularly abnormalities in the heart’s electrical conduction system that controls heartbeat. These cardiac conduction defects can lead to irregular heartbeats or heart block^[1][11].

Respiratory muscle weakness can develop, particularly in type 1, affecting breathing capacity. Some people develop sleep apnea or decreased breathing drive. Digestive problems may occur due to weakness in smooth muscles of the digestive tract, causing difficulties with swallowing or gastrointestinal disturbances. Hormone-related issues are also possible, including insulin resistance that can lead to diabetes, thyroid problems, and fertility issues. In men, early balding and infertility may occur^[1][12].

Some people with myotonic dystrophy experience cognitive changes, personality abnormalities, or reduced cognitive function. Excessive daytime sleepiness is common and can significantly impact daily activities and quality of life^[12].

The congenital form of myotonic dystrophy type 1, which affects infants, presents with severe symptoms at birth including weak muscle tone (hypotonia), breathing difficulties, feeding problems, and clubfoot. These babies may also experience delayed development and intellectual disability. The childhood form, beginning around age 10, is characterized by learning disabilities, behavioral issues, and progressive muscle weakness^[1][11].

One important aspect of myotonic dystrophy is its variability. Even within the same family, the severity and range of symptoms can vary greatly. Some people have mild symptoms affecting only muscles and eyes late in life, while others experience severe, life-threatening complications. This makes it impossible for doctors to predict exactly how the condition will affect any individual person^[12].

Prevention: Can Myotonic Dystrophy Be Prevented?

Because myotonic dystrophy is an inherited genetic condition, there is no way to prevent someone who has inherited the genetic mutation from developing the condition. However, there are important steps people can take regarding family planning and genetic counseling.

For families affected by myotonic dystrophy, genetic counseling is valuable. Genetic counselors can help people understand their risk of passing the condition to their children and explain the pattern of inheritance. They can discuss the phenomenon of anticipation, where the condition may become more severe in subsequent generations, particularly when passed from mother to child^[3].

Prenatal testing is available for families who know they carry the mutation. This can help expectant parents understand whether their baby has inherited the genetic change and, if so, approximately how many DNA repeats are present, which gives some indication of likely severity. Some families may choose to pursue predictive testing for at-risk family members who have not yet developed symptoms^[4].

While the genetic condition itself cannot be prevented, many of its complications can be managed or their impact reduced through appropriate medical care and lifestyle modifications. Regular monitoring can help detect problems early, particularly heart conduction abnormalities and breathing difficulties. Early detection and management of these complications can improve outcomes and quality of life^[11].

Pathophysiology: How the Condition Changes Body Function

The pathophysiology of myotonic dystrophy involves complex cellular and molecular changes that affect how muscles and other tissues function. The expanded DNA repeats in the affected genes are transcribed into abnormally long RNA molecules. These RNA molecules accumulate in the cell nucleus, forming distinctive clumps or foci that can be seen under a microscope^[11].

These accumulated RNA molecules trap and sequester important RNA-binding proteins, particularly muscleblind protein. When these proteins are trapped, they cannot perform their normal functions in the cell. One of their key roles is regulating alternative splicing, a process that determines how genetic information is used to make proteins. When this process goes wrong, many proteins throughout the body are made incorrectly or in wrong proportions^[4][11].

In muscle tissue, these disrupted cellular processes lead to several functional changes. The myotonia—the inability to relax muscles—occurs because of abnormal function of chloride channels in muscle cell membranes. These channels normally help muscles relax after contraction. When they don’t work properly, the muscle membrane continues to be electrically active, causing sustained muscle contraction even when the person tries to relax^[3].

Progressive muscle weakness and wasting occur because the cellular dysfunction affects muscle maintenance and regeneration. Muscle fibers gradually deteriorate and are not properly replaced. Under the microscope, muscle tissue from people with myotonic dystrophy shows characteristic changes including variation in fiber size, increased central nuclei in muscle cells, and other structural abnormalities^[3].

The heart problems in myotonic dystrophy result from similar processes affecting cardiac muscle and the heart’s electrical conduction system. The specialized cells that coordinate heartbeat are disrupted, leading to conduction defects that can cause irregular heart rhythms or heart block, where electrical signals don’t properly travel through the heart^[1].

In the eyes, the disrupted cellular processes affect lens proteins, leading to early cataract formation. In other organs and systems, similar molecular disruptions cause the wide range of symptoms observed in myotonic dystrophy, from insulin resistance and diabetes to cognitive changes and excessive sleepiness. The multisystem nature of the condition reflects that the affected genes and their downstream effects play important roles in many different cell types throughout the body^[12].

The severity of these pathophysiological changes in type 1 myotonic dystrophy correlates with the number of CTG repeats in the gene. More repeats generally mean more abnormal RNA accumulation, more trapped proteins, and more severe cellular dysfunction. This is why people with larger repeat expansions typically have more severe symptoms^[3].